MEDTRONIC TAVR TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)

A PARADIGM SHIFT IN THE MANAGEMENT OF PATIENTS WITH SEVERE AORTIC STENOSIS

Transcatheter aortic valve replacement (TAVR) is a minimally invasive, catheter-based procedure to replace the function of the aortic valve.


A LESS INVASIVE TREATMENT OPTION

TAVR may be an excellent option for certain patients because the prevalence of aortic stenosis and co-morbidities increase the risks associated with surgical aortic valve implantation (SAVI).1 Without intervention, the average symptomatic patient life expectancy is 2 to 5 years.2

 

LEARN ABOUT TAVR

Bioprosthetic valve partially expanded

PREVALENCE OF 

SEVERE AORTIC STENOSIS

Approximately 300,000 people in the U.S. are diagnosed annually with symptomatic, severe aortic stenosis.3

LEARN ABOUT PATIENT SELECTION
This graphic shows the incidence of symptomatic severe aortic stenosis as approximately 300,000.

MEDTRONIC 

SUPPORT

Medtronic has resources to help you start and build your TAVR program.

SEE BENEFITS OF THE PROGRAM
1

Schwartz F, et al. The effect of aortic valve replacement on survival Circulation. 1982:66:1105-1110.

2

Lester SJ, Heilbron B, Gin K, et al. The natural history and rate of progression of aortic stenosis. Chest 1998; 113:1109-14.

3

Medtronic data on file.